Profil
Ehab Elkhouly worked as an Operations Director at Response Genetics, Inc. He then worked at Cancer Genetics, Inc. as a VP-Clinical Affairs & Site Operations from 2018 to 2019.
Dr. Elkhouly has an undergraduate degree from KasrAlAiny School of Medicine and a graduate degree from Paul Merage School of Business.
Ehemalige bekannte Positionen von Ehab Elkhouly
| Unternehmen | Position | Ende |
|---|---|---|
| CANCER GENETICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 |
| RESPONSE GENETICS, INC | Geschäftsführer | - |
Ausbildung von Ehab Elkhouly
| KasrAlAiny School of Medicine | Undergraduate Degree |
| Paul Merage School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
